aap Implantate AG

XETRA AAQ1.DE

aap Implantate AG Free Cash Flow Yield on February 03, 2025: -16.13%

aap Implantate AG Free Cash Flow Yield is -16.13% on February 03, 2025, a 53.83% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

aap Implantate AG 52-week high Free Cash Flow Yield is -8.08% on October 15, 2024, which is 49.90% above the current Free Cash Flow Yield.
aap Implantate AG 52-week low Free Cash Flow Yield is -34.94% on February 05, 2024, which is -116.59% below the current Free Cash Flow Yield.
aap Implantate AG average Free Cash Flow Yield for the last 52 weeks is -19.95%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

XETRA: AAQ1.DE

aap Implantate AG

CEO	Mr. Rubino Di Girolamo
IPO Date	May 11, 1999
Location	Germany
Headquarters	Lorenzweg 5
Employees	87
Sector	Healthcare
Industries Medical Instruments 3D Printing Automotive Parts Composite Materials Glass Hardware & Electronics Pharmaceuticals Plastics

Description

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Key trends

Past 5 years